Jazz Pharmaceuticals plc (JAZZ) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Jazz Pharmaceuticals plc (JAZZ) Bundle
Gain insight into your Jazz Pharmaceuticals plc (JAZZ) valuation analysis with our state-of-the-art DCF Calculator! This Excel template comes preloaded with real (JAZZ) data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of Jazz Pharmaceuticals plc.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,161.8 | 2,363.6 | 3,094.2 | 3,659.4 | 3,834.2 | 4,440.9 | 5,143.5 | 5,957.4 | 6,900.0 | 7,991.8 |
| Revenue Growth, % | 0 | 9.34 | 30.91 | 18.26 | 4.78 | 15.82 | 15.82 | 15.82 | 15.82 | 15.82 |
| EBITDA | 1,012.5 | 649.7 | 1,027.7 | 553.8 | 1,287.7 | 1,387.8 | 1,607.4 | 1,861.8 | 2,156.4 | 2,497.5 |
| EBITDA, % | 46.84 | 27.49 | 33.21 | 15.13 | 33.59 | 31.25 | 31.25 | 31.25 | 31.25 | 31.25 |
| Depreciation | 370.2 | 278.3 | 552.5 | 629.5 | 638.7 | 716.0 | 829.2 | 960.5 | 1,112.4 | 1,288.4 |
| Depreciation, % | 17.12 | 11.77 | 17.86 | 17.2 | 16.66 | 16.12 | 16.12 | 16.12 | 16.12 | 16.12 |
| EBIT | 642.3 | 371.4 | 475.3 | -75.7 | 649.0 | 671.9 | 778.2 | 901.3 | 1,043.9 | 1,209.1 |
| EBIT, % | 29.71 | 15.71 | 15.36 | -2.07 | 16.93 | 15.13 | 15.13 | 15.13 | 15.13 | 15.13 |
| Total Cash | 1,077.3 | 2,132.8 | 591.4 | 881.5 | 1,626.3 | 2,004.5 | 2,321.7 | 2,689.1 | 3,114.5 | 3,607.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 356.0 | 396.5 | 563.4 | 651.5 | 705.8 | 778.6 | 901.8 | 1,044.5 | 1,209.7 | 1,401.1 |
| Account Receivables, % | 16.47 | 16.78 | 18.21 | 17.8 | 18.41 | 17.53 | 17.53 | 17.53 | 17.53 | 17.53 |
| Inventories | 78.6 | 95.4 | 1,072.7 | 714.1 | 597.0 | 687.7 | 796.5 | 922.5 | 1,068.5 | 1,237.5 |
| Inventories, % | 3.64 | 4.04 | 34.67 | 19.51 | 15.57 | 15.49 | 15.49 | 15.49 | 15.49 | 15.49 |
| Accounts Payable | 47.5 | 26.9 | 100.3 | 90.8 | 102.8 | 104.3 | 120.8 | 139.9 | 162.0 | 187.7 |
| Accounts Payable, % | 2.2 | 1.14 | 3.24 | 2.48 | 2.68 | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
| Capital Expenditure | -182.3 | -379.3 | -45.5 | -498.2 | -24.0 | -357.0 | -413.4 | -478.9 | -554.6 | -642.4 |
| Capital Expenditure, % | -8.43 | -16.05 | -1.47 | -13.61 | -0.62495 | -8.04 | -8.04 | -8.04 | -8.04 | -8.04 |
| Tax Rate, % | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 | -39.24 |
| EBITAT | 740.0 | 322.2 | 1,385.5 | -43.5 | 903.7 | 596.9 | 691.3 | 800.7 | 927.4 | 1,074.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 540.8 | 143.3 | 821.6 | 348.8 | 1,593.2 | 794.0 | 891.6 | 1,032.7 | 1,196.1 | 1,385.3 |
| WACC, % | 6.31 | 6.05 | 6.31 | 5.47 | 6.31 | 6.09 | 6.09 | 6.09 | 6.09 | 6.09 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 4,380.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 1,413 | |||||||||
| Terminal Value | 34,548 | |||||||||
| Present Terminal Value | 25,707 | |||||||||
| Enterprise Value | 30,087 | |||||||||
| Net Debt | 4,285 | |||||||||
| Equity Value | 25,802 | |||||||||
| Diluted Shares Outstanding, MM | 72 | |||||||||
| Equity Value Per Share | 358.04 |
What You Will Receive
- Flexible Forecast Inputs: Adjust key assumptions (growth %, margins, WACC) effortlessly to explore various scenarios.
- Comprehensive Data: Jazz Pharmaceuticals' financial information pre-loaded to facilitate your analysis.
- Instant DCF Outputs: The template automatically computes Net Present Value (NPV) and intrinsic value for you.
- Tailored and Professional: A sleek Excel model designed to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- 🔍 Real-Life JAZZ Financials: Pre-filled historical and projected data for Jazz Pharmaceuticals plc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Jazz’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Jazz’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file containing Jazz Pharmaceuticals plc’s (JAZZ) financial data.
- 2. Modify Assumptions: Adjust key parameters such as growth projections, WACC, and capital expenditures.
- 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation insights to enhance your decision-making process.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Comprehensive Data: Jazz Pharmaceuticals' historical and projected financials are preloaded for precision.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Clear Results: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance leads you through the calculation process.
Who Should Use Jazz Pharmaceuticals plc (JAZZ)?
- Investors: Make informed decisions with a comprehensive analysis of Jazz Pharmaceuticals' market performance.
- Pharmaceutical Analysts: Streamline your research with detailed insights into product pipelines and financials.
- Consultants: Easily tailor presentations or reports focused on Jazz Pharmaceuticals for your clients.
- Healthcare Enthusiasts: Enhance your knowledge of the pharmaceutical industry by exploring real-world case studies of Jazz Pharmaceuticals.
- Educators and Students: Utilize it as a valuable resource in pharmaceutical and finance courses.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Jazz Pharmaceuticals historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Jazz Pharmaceuticals.
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.